Giovanni Fava (psychiatrist)

Last updated

Giovanni Andrea Fava (born 10 June 1952 in Valdagno) [1] is an Italian psychiatrist and former professor of clinical psychology at the University of Bologna. He is also a clinical professor of psychiatry at the University at Buffalo School of Medicine and Biomedical Sciences.

Contents

Education and career

Fava received his medical degree from the University of Padova in 1977, where he went on to complete his residency in psychiatry in 1981. After working for several years in the US (Albuquerque and Buffalo, N.Y.), he returned to Italy in 1988, becoming Associate Professor of Psychosomatic Medicine in the Department of Psychology of the University of Bologna, while keeping his ties with the State University of New York at Buffalo. He has been a professor of clinical psychology at the University of Bologna since 1997 and a clinical professor of psychiatry at the University at Buffalo's School of Medicine since 1999. [1] From 1992 to 2022, he was the editor-in-chief of the peer-reviewed medical journal Psychotherapy and Psychosomatics . [2]

Research

Fava has authored more than 500 scientific papers and performed research in several fields. His main areas of interest have been diagnosis and treatment of affective disorders and psychosomatic medicine. Fava is known for researching the adverse effects of antidepressant drugs, such as their potential to trigger a relapse among depressed patients. [3] In a 1994 editorial, he argued that many of his fellow psychiatrists were too hesitant to question whether a given psychiatric treatment was more harmful than it was helpful. [4] He has also studied hypochondriasis and how it can be treated, [5] and the frequency with which patients with medical illnesses become demoralized about their condition. [6]

He has also developed well-being therapy, a therapy aimed at preventing patients recovering from depression from relapsing. [7] [8] [9] It has been described as a method to promote psychological resilience. [10]

Related Research Articles

<span class="mw-page-title-main">Major depressive disorder</span> Mental disorder involving persistent low mood, low self-esteem, and loss of interest

Major depressive disorder (MDD), also known as clinical depression, is a mental disorder characterized by at least two weeks of pervasive low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities. Introduced by a group of US clinicians in the mid-1970s, the term was adopted by the American Psychiatric Association for this symptom cluster under mood disorders in the 1980 version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), and has become widely used since.

Psychosomatic medicine is an interdisciplinary medical field exploring the relationships among social, psychological, behavioral factors on bodily processes and quality of life in humans and animals.

<span class="mw-page-title-main">Psychiatric medication</span> Medication used to treat mental disorders

A psychiatric or psychotropic medication is a psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system. Thus, these medications are used to treat mental illnesses. These medications are typically made of synthetic chemical compounds and are usually prescribed in psychiatric settings, potentially involuntarily during commitment. Since the mid-20th century, such medications have been leading treatments for a broad range of mental disorders and have decreased the need for long-term hospitalization, thereby lowering the cost of mental health care. The recidivism or rehospitalization of the mentally ill is at a high rate in many countries, and the reasons for the relapses are under research.

<i>The Myth of Mental Illness</i> 1961 book by Thomas Szasz

The Myth of Mental Illness: Foundations of a Theory of Personal Conduct is a 1961 book by the psychiatrist Thomas Szasz, in which the author criticizes psychiatry and argues against the concept of mental illness. It received much publicity, and has become a classic, well known as an argument that "mentally ill" is a label which psychiatrists have used against people "disabled by living" rather than truly having a disease.

<span class="mw-page-title-main">David Healy (psychiatrist)</span> Irish-born pharmacologist

David HealyFRCPsych, a professor of psychiatry at Bangor University in the United Kingdom, is a psychiatrist, psychopharmacologist, scientist and author. His main areas of research are the contribution of antidepressants to suicide, conflict of interest between pharmaceutical companies and academic medicine, and the history of pharmacology. Healy has written more than 150 peer-reviewed articles, 200 other articles, and 20 books, including The Antidepressant Era, The Creation of Psychopharmacology, The Psychopharmacologists Volumes 1–3, Let Them Eat Prozac and Mania: A Short History of Bipolar Disorder.

Peter Roger Breggin is an American psychiatrist and critic of shock treatment and psychiatric medication and COVID-19 response. In his books, he advocates replacing psychiatry's use of drugs and electroconvulsive therapy with psychotherapy, education, empathy, love, and broader human services.

Biological psychiatry or biopsychiatry is an approach to psychiatry that aims to understand mental disorder in terms of the biological function of the nervous system. It is interdisciplinary in its approach and draws on sciences such as neuroscience, psychopharmacology, biochemistry, genetics, epigenetics and physiology to investigate the biological bases of behavior and psychopathology. Biopsychiatry is the branch of medicine which deals with the study of the biological function of the nervous system in mental disorders.

A major depressive episode (MDE) is a period characterized by symptoms of major depressive disorder. Those affected primarily exhibit a depressive mood for at least two weeks or more, and a loss of interest or pleasure in everyday activities. Other symptoms can include feelings of emptiness, hopelessness, anxiety, worthlessness, guilt, irritability, changes in appetite, difficulties in concentration, difficulties remembering details, making decisions, and thoughts of suicide. Insomnia or hypersomnia and aches, pains, or digestive problems that are resistant to treatment may also be present.

Mental disorders are classified as a psychological condition marked primarily by sufficient disorganization of personality, mind, and emotions to seriously impair the normal psychological and often social functioning of the individual. Individuals diagnosed with certain mental disorders can be unable to function normally in society. Mental disorders may consist of several affective, behavioral, cognitive and perceptual components. The acknowledgement and understanding of mental health conditions has changed over time and across cultures. There are still variations in the definition, classification, and treatment of mental disorders.

<span class="mw-page-title-main">David D. Burns</span> American professor of psychiatry

David D. Burns is an American psychiatrist and adjunct professor emeritus in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. He is the author of bestselling books such as Feeling Good: The New Mood Therapy, The Feeling Good Handbook and Feeling Great: The Revolutionary New Treatment for Depression and Anxiety.

Psychiatry is the medical specialty devoted to the diagnosis, prevention, and treatment of deleterious mental conditions. These include various matters related to mood, behaviour, cognition, and perceptions.

Management of depression is the treatment of depression that may involve a number of different therapies: medications, behavior therapy, psychotherapy, and medical devices.

This is a timeline of the modern development of psychiatry. Related information can be found in the Timeline of psychology and Timeline of psychotherapy articles.

Muhamad Aly Rifai is a Syrian American internist and psychiatrist and a clinician researcher known for describing the association between psychiatric disorders and hepatitis C. He co-authored a clinical report detailing the association between hepatitis C infection and psychiatric disorders. Rifai has lied about his status as the Director of the Older Adults Behavioral Health Unit at Easton Hospital in Easton, Pennsylvania. He is the President and CEO of Blue Mountain Psychiatry which has locations in Pennsylvania.

Allen J. Frances is an American psychiatrist. He is currently Professor and Chairman Emeritus of the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine. He is best known for serving as chair of the American Psychiatric Association task force overseeing the development and revision of the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Frances is the founding editor of two well-known psychiatric journals: the Journal of Personality Disorders and the Journal of Psychiatric Practice.

The following outline is provided as an overview of and topical guide to psychiatry:

<i>Doctoring the Mind</i>

Doctoring the Mind: Why psychiatric treatments fail is a 2009 book by Richard Bentall, his thesis is critical of contemporary Western psychiatry. Bentall, a professor of clinical psychology, argues that recent scientific research shows that the medical approach to mental illness is fatally flawed. According to Bentall, it seems there is no "evidence that psychiatry has made a positive impact on human welfare" and "patients are doing no better today than they did a hundred years ago".

Augustus John Rush is an internationally renowned psychiatrist. He is a professor emeritus in Duke-NUS Medical School at the National University of Singapore (NUS), and adjunct professor of psychiatry and behavioral sciences at Duke University School of Medicine. He has authored and edited more than 10 books, and over 600 scientific journal articles that are largely focused on the diagnosis and treatment of depressive and bipolar disorders.

<span class="mw-page-title-main">Michael A. Schwartz</span> American academic and psychiatrist

Michael Alan Schwartz is an American academic and psychiatrist based in Weston, Connecticut. In 2018 Schwartz retired as clinical professor of psychiatry and joint professor of humanities in medicine at the Texas A&M School of Medicine. He continues practicing psychiatry as well as writing and editing psychiatric books and articles. His work focuses on advancing pluralistic, person and people-centered approaches to psychiatric assessment, care and treatment.

Claudi Bockting is a Dutch clinical psychologist and Professor of Clinical Psychology in Psychiatry at the University of Amsterdams Faculty of Medicine, Amsterdam University Medical Centers. Her research program focuses on identifying etiological factors of common mental health disorders such as depression, anxiety disorders and substance abuse, and developing evidence-based psychotherapeutic interventions.

References

  1. 1 2 "Giovanni Andrea Fava Curriculum Vitae". University of Bologna Website. Archived from the original on 22 August 2017. Retrieved 22 May 2017.
  2. Karger, Gabriella (5 July 2022). "Farewell to Prof. Giovanni A. Fava after 30 Years and Welcome to the New Editors". Psychotherapy and Psychosomatics. 91 (4): 217. doi: 10.1159/000525872 . Retrieved 6 November 2023.
  3. Schwartz, Casey (15 June 2011). "Do Antidepressants Make You Sad?". The Daily Beast . Retrieved 22 May 2017.
  4. Whitaker, Robert (2011). Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America. Broadway Books. p. 159. ISBN   9780307452429.
  5. Norman, Matthew (6 June 2000). "Diary of a hypochondriac". The Guardian . Retrieved 22 May 2017.
  6. Arehart-Treichel, Joan (3 June 2005). "Demoralization Frequent Companion Of Serious Medical Illness". Psychiatric News. 40 (11): 10–33. doi:10.1176/pn.40.11.00400010.
  7. Rosensweig, Jeffrey; Liu, Betty (2011). Age Smart: Discovering the Fountain of Youth at Midlife and Beyond. Prentice Hall Professional. pp. 98–99. ISBN   9780132703161.
  8. Fava, GA (1999). "Well-Being Therapy: Conceptual and Technical Issues". Psychotherapy and Psychosomatics. 68: 171–179. doi:10.1159/000012329. PMID   10396007.
  9. Fava, GA; Rafanelli, C; Cazzaro, M; Conti, S; Grandi, S (1998). "Well-being therapy: a novel psychotherapeutic approach for residual symptoms of affective disorders". Psychol Med. 28: 475–480. doi:10.1017/s0033291797006363. PMID   9572104.
  10. Ryff, Carol D; Singer, Burton (2008). "10: Thriving in the Face of Challenge: The Integrative Science of Resiliency". In Kessel, Frank; Rosenfield, Patricia; Anderson, Norman (eds.). Expanding the Boundaries of Health and Social Science: Case Studies in Interdisciplinary Innovation. Oxford University Press. ISBN   9780190295905.